Interested in attending BIONATION 2024 in Ottawa?

If you are not a BIOTECanada member and are interested in attending BIONATION 2024 request an invitation here

BIONATION is the national federal policy event showcasing the vibrant biotechnology network in Canada. The event has become key for fostering a comprehensive understanding of Canada’s biotech landscape; promoting a more integrated policy environment conducive to attracting investment and modernizing regulatory decision making; and supporting a healthy biotech ecosystem leading to more research and development for company creation and growth.

BIONATION 2024 will be held on September 24-25, 2024 in Ottawa. The event provides an up-close learning opportunity of the Canadian biotech industry leading to an increased awareness publicly, and amongst policymakers, of the value of the biotech industry, and the important social and economic benefit of a robust domestic biotech ecosystem. Program information will be available in the Spring.

BIOTECanada is pleased to welcome initial sponsors and partners for BIONATION 2024. If your organization is interested in partnering with BIOTECanada on this event, contact Cate McCready, Vice President, External Affairs.


The BIONATION program was created in 2020 by BIOTECanada as a platform for a national dialogue on the achievements and developments of the biotechnology ecosystem in Canada. BIONATION hosts events, develops policy papers and resources, and ultimately connects Canada’s biotechnology entrepreneurs and research and development leaders with the government. BIONATION has helped to make Canada a biomanufacturing and life sciences powerhouse. Today, more than 900 innovative Canadian biotechnology companies anchor our national discovery and development network. The ecosystem driving the network is an economic catalyst present in every Canadian region and is driving the unprecedented opportunities that lay ahead.  

BIONATION 2023 Highlights

Investing in BIONATION

Beginning with the 2021 federal budget, the Government of Canada has made significant investments to build out the domestic life sciences ecosystem and enhance Canada’s biomanufacturing capacity: The $350 million Venture Capital Catalyst Initiative (VCCI) included a Life sciences stream of up to $50 million In 2023, The $2.6 billion Canada Innovation Corporation (CIC) was created to drive Canadian business investment in research and development (R&D).  The Council of Expert Advisors (CEA) will advise the Government of Canada on the long-term, sustainable growth of Canada’s biomanufacturing and life sciences sector, and how to enhance our ability to protect the health and safety of Canadians. Canada’s first-ever National Strategy for Drugs for Rare Diseases makes available up to $1.4 billion over three years to provinces and territories to improve access to new and emerging drugs for Canadians with rare diseases.

Our Moment is Now

We have made incredible progress over the past few years, but we must not take our foot off the gas. Every other leading economic jurisdiction in the world is also investing heavily in their domestic life sciences sectors as they too understand the vital role biotechnology innovation plays in the global economy. 

Now through BIONATION we are focusing on the next set of policy reforms and programs to build a more globally competitive Canada.